Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study.

AUTOR(ES)

Brooks, P M

RESUMO

The addition of phenobarbitone in therapeutic dosage to the drug regimen of prednisolone-treated subjects with rheumatoid arthritis produced measurable deterioration in the clinical status of the patients associated with a more rapid clearance of prednisolone from plasma. It is considered that phenobarbitone induced the hepatic metabolism of prednisolone, effectively reducing the steady state plasma level and resulting in clinical relapse. A slight but significant improvement in the adrenocortical response to tetracosactrin (Synacthen) was noted after phenobarbitone therapy.

Documentos Relacionados

• Effects of prednisolone on angiotensin converting enzyme activity.
• Genital ulcers in Kenya. Clinical and laboratory study.
• Chronic cyanide exposure: a clinical, radioisotope, and laboratory study.
• Effects of exposure to cadmium on calcium metabolism: a population study.
• Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone.